Nanollose Limited (NC6.AX)

AUD 0.02

(0.0%)

Total Debt Summary of Nanollose Limited

  • Nanollose Limited's latest annual total debt in 2024 was 42.53 Thousand AUD , up 269.22% from previous year.
  • Nanollose Limited's latest quarterly total debt in 2024 FY was 42.53 Thousand AUD , up 269.22% from previous quarter.
  • Nanollose Limited reported annual total debt of 11.51 Thousand AUD in 2023, down -69.76% from previous year.
  • Nanollose Limited reported annual total debt of 38.09 Thousand AUD in 2022, up 0.56% from previous year.
  • Nanollose Limited reported quarterly total debt of 400.47 Thousand AUD for 2024 Q2, up 3376.6% from previous quarter.
  • Nanollose Limited reported quarterly total debt of 42.53 Thousand AUD for 2024 Q4, down -89.38% from previous quarter.

Annual Total Debt Chart of Nanollose Limited (2024 - 2015)

Historical Annual Total Debt of Nanollose Limited (2024 - 2015)

Year Total Debt Total Debt Growth
2024 42.53 Thousand AUD 269.22%
2023 11.51 Thousand AUD -69.76%
2022 38.09 Thousand AUD 0.56%
2021 37.88 Thousand AUD -34.83%
2020 58.12 Thousand AUD 0.0%
2019 - AUD 0.0%
2018 - AUD -100.0%
2017 5973.00 AUD -62.67%
2016 16 Thousand AUD 0.0%
2015 16 Thousand AUD 0.0%

Peer Total Debt Comparison of Nanollose Limited

Name Total Debt Total Debt Difference
EZZ Life Science Holdings Limited 123.85 Thousand AUD 65.662%
Anatara Lifesciences Ltd - AUD -Infinity%
Zelira Therapeutics Limited 5.65 Million AUD 99.248%
Biome Australia Limited 1.3 Million AUD 96.743%
Patrys Limited - AUD -Infinity%
Orthocell Limited 689.69 Thousand AUD 93.833%
Imugene Limited 1.54 Million AUD 97.251%
Noxopharm Limited - AUD -Infinity%
PYC Therapeutics Limited 1.11 Million AUD 96.178%
Chimeric Therapeutics Limited - AUD -Infinity%
Prescient Therapeutics Limited 330.48 Thousand AUD 87.131%
Proteomics International Laboratories Limited 316.39 Thousand AUD 86.558%
Cynata Therapeutics Limited - AUD -Infinity%
CSL Limited 18.24 Billion AUD 100.0%
Arovella Therapeutics Limited - AUD -Infinity%
Bio-Gene Technology Limited - AUD -Infinity%
Clinuvel Pharmaceuticals Limited 879.78 Thousand AUD 95.166%
Starpharma Holdings Limited 3.52 Million AUD 98.795%
Memphasys Limited 4.41 Million AUD 99.036%
Invex Therapeutics Ltd - AUD -Infinity%
NeuroScientific Biopharmaceuticals Limited - AUD -Infinity%
Amplia Therapeutics Limited 1.56 Million AUD 97.277%
Botanix Pharmaceuticals Limited - AUD -Infinity%
Island Pharmaceuticals Limited 421.96 Thousand AUD 89.921%
Race Oncology Limited - AUD -Infinity%
Nyrada Inc. - AUD -Infinity%
Telix Pharmaceuticals Limited 17.44 Million AUD 99.756%
Dimerix Limited 149.68 Thousand AUD 71.587%
PharmAust Limited - AUD -Infinity%
Immutep Limited 1.22 Million AUD 96.537%
Clarity Pharmaceuticals Ltd - AUD -Infinity%
Alterity Therapeutics Limited 159.04 Thousand AUD 73.259%
BTC Health Limited - AUD -Infinity%
Acrux Limited 1.48 Million AUD 97.14%
Neuren Pharmaceuticals Limited - AUD -Infinity%
Biotron Limited 7130.00 AUD -496.494%
Tissue Repair Ltd - AUD -Infinity%
AdAlta Limited 2.49 Million AUD 98.295%
Radiopharm Theranostics Limited - AUD -Infinity%
Hexima Limited - AUD -Infinity%
AnteoTech Limited 23.59 Thousand AUD -80.273%
Paradigm Biopharmaceuticals Limited 239.33 Thousand AUD 82.23%
Recce Pharmaceuticals Ltd 811.19 Thousand AUD 94.757%
Avecho Biotechnology Limited 175.15 Thousand AUD 75.718%
Actinogen Medical Limited 319.06 Thousand AUD 86.671%
Immuron Limited 173.49 Thousand AUD 75.487%
Argenica Therapeutics Limited - AUD -Infinity%